Recent Posts

AstraZeneca cancer drug gets first Japan approval

  Bloomberg AstraZeneca Plc’s new drug Imjudo won approval in Japan for two different cancer types when added to the blockbuster medicine Imfinzi, widening the immune therapy’s reach. The treatment, a monoclonal antibody, is now authorised for forms of lung and liver cancer in Japan for patients who are also receiving Imfinzi, Astra said. The approval, coming after clearance in ...

Read More »

Philippines PLDT in talks with four major vendors

Bloomberg PLDT Inc said it is in discussions with four major vendors for equipment and assets covered by its 48-billion peso ($859 million) overspending that stretched over four years from 2019. While the Philippines’ biggest phone company didn’t specify the nature of its discussions with the firms, namely Cisco Systems Inc, Huawei Technologies Co Ltd, Ericsson and Fiberhome Telecom in ...

Read More »

Singapore technology stock rout intensifies with $110b wipeout

  Bloomberg Investors betting on Singapore’s two largest internet companies are staring down hefty losses as rising interest rates and recession risks extended a tech rout that wiped out $110 billion from their market capitalisation. E-commerce platform operator Sea Ltd plunged 78% this year while ride-hailing firm Grab Holdings Ltd has more than halved. The two companies, both listed in ...

Read More »
Send this to a friend